Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214675) titled 'The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy' on Oct. 3.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: HistoSonics, Inc.

Condition: Benign Prostatic Hyperplasia

Intervention: Device: HistoSonics Edison System

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 2026

Target Sample Size: 80

To know more, visit https://clinicaltrials.gov/study/NCT07214675

Published by HT Digital Content Services with permissio...